Tubulointerstitial nephritis and uveitis (TINU) syndrome: epidemiology, diagnosis and management
2008; Oxford University Press; Volume: 1; Issue: 2 Linguagem: Inglês
10.1093/ndtplus/sfn006
ISSN2048-8513
AutoresK. Sinnamon, Aisling E. Courtney, Camille Harron, Declan O’Rourke, Robert Mullan,
Tópico(s)Drug-Induced Hepatotoxicity and Protection
ResumoAcute tubulointerstitial nephritis is demonstrated in 2–3% of all native renal biopsies, increasing to 10–15% if the biopsy is performed in the setting of acute renal failure [1]. It is most commonly related to medication or infection [1,2]. An increasingly recognized entity is tubulointerstitial nephritis with uveitis (TINU) syndrome. We outline the clinical course of a patient with TINU syndrome and review the changes in epidemiology, diagnosis and management.
Referência(s)